Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer,
CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference
A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the webcast will be archived on the Company's website for 14 days following the presentation.
ANI Pharmaceuticals To Present At The Guggenheim Biotech Conference
The live and archived webcast will be accessible from the Company's website at , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 60 days.
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies,
Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.
Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Feb.
U.S. News & World Report3mon
The Guggenheim
The Solomon R. Guggenheim Museum, or simply, "The Guggenheim," is one of the most well-known art museums in the country, and it's just as renowned for its cutting-edge design as it is for its ...
Reuters10d
Guggenheim expects Fed to cut rates about every quarter in 2025
DAVOS, Switzerland, Jan 20 (Reuters) - Guggenheim Partners' chief investment officer forecast on Monday that the U.S. Federal Reserve is likely to cut interest rates roughly every quarter in 2025 ...
Morningstar1mon
Guggenheim Investments Announces December 2024 Closed-End Fund Distributions
Section 19(a) notices are provided for informational ... Consult a professional regarding your specific legal or tax matters. Guggenheim Investments is the global asset management and investment ...
U.S. News & World Report9d
Peggy Guggenheim Collection
Expat American art collector Peggy Guggenheim dedicated her life to gathering this impressive body of 20th-century contemporary art. The collection, which is housed in the Palazzo Venier dei Leoni ...
EnVols on MSN16d
The Guggenheim Museum Bilbao, when art reinvents the city
Unmissable on the banks of the Nervión River, the audacious and lyrical Guggenheim Museum Bilbao is as much a work of art as the collections it contains within its curved walls.
Morningstar2mon
Guggenheim Municipal Income A
Guggenheim Municipal Income Fund earns a Below Average Process Pillar rating. The process benefits from the parent firm's five-year risk-adjusted success ratio of 57%. The measure indicates the ...